ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Type 2 Diabetes
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

"Approximately 3 hours of ACT will be administered based on Gregg et al.;s (2007) protocol:~1. What is ACT?~2. Coping and Stress Management~3. Acceptance and Action"

DEVICE

Abbott FreeStyle® Libre® 3

The Abbott FreeStyle® Libre® 3 (FDA approved) consists of a single use disposable electrochemical sensing unit which is placed on the upper arm and an App for smart phones where the participant can view their glucose data, including their current glucose reading, their 'trend arrow' so participants can see how glucose is changing, and their glucose history. The FreeStyle system does not require user calibration. A sensor log will be maintained for accountability of all sensors received as well as used sensors (including the lot/serial number, expiration date, and the date). Sensors will be stored at manufacturers recommendations.

OTHER

Generic Education

Participants will be given information about how lifestyle choices, including daily dietary choices, affect blood sugar for people with T2D, and best practices related to checking blood sugar and carbohydrate counting if participants are on insulin therapy. These sessions will also include education on diabetes nutrition guidelines and improving self-management through better food and lifestyle choices.

Trial Locations (1)

77304

RECRUITING

Sam Houston State University College of Osteopathic Medicine, Conroe

All Listed Sponsors
collaborator

Chelsea Ratcliff, Ph.D.

UNKNOWN

collaborator

Owen Kelly, Ph.D.,RNutr

UNKNOWN

collaborator

Oluwaseun Olaiya, DO

UNKNOWN

collaborator

Michael Griffin, Ph.D.

UNKNOWN

lead

Sam Houston State University

OTHER